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Expanded 3D Nanofiber Scaffolds: Cell Penetration,
Neovascularization, and Host Response
Jiang Jiang, Zhuoran Li, Hongjun Wang, Yue Wang, Mark A. Carlson,
Matthew J. Teusink, Matthew R. MacEwan, Linxia Gu, and Jingwei Xie*
bioactive signaling molecules and pharmaceutical agents capable of positively
influencing cellular behavior.[4] Nanotopographic cues rendered by electrospun
nanofibers have demonstrated the ability
to guide cellular morphology, migration,
and differentiation.[5] However, one major
drawback that lies in traditional electrospun nanofiber membranes is the small
pore size resulting from tightly packed
nanofiber layers, which limits cellular
infiltration and 3D tissue formation.[6]
3D scaffolds composed of electrospun
nanofibers that promote cellular infiltration therefore may represent an improved
synthetic matrix for use in tissue repair/
regeneration, and provide a better mimic
for both the structure and composition of
targeted tissues.[7]
In order to improve the modeling of
native tissue structure, many attempts
have been made to fabricate 3D electrospun nanofiber scaffolds. Jun and
co-workers designed a unique collector consisting of a
grounded spherical dish and an array of needle-like probes
for creation of a focused, low density, uncompressed poly(εcaprolactone) (PCL) nanofiber scaffold.[8] In order to promote
electron transfer from deposited fibers to the collector and
achieve repulsion between deposited fibers and the collector
during electrospinning, Yang and co-workers used a negatively charged spinneret and a positively charged collector

Herein, a robust method to fabricate expanded nanofiber scaffolds with
controlled size and thickness using a customized mold during the modified
gas-foaming process is reported. The expansion of nanofiber membranes
is also simulated using a computational fluid model. Expanded nanofiber
scaffolds implanted subcutaneously in rats show cellular infiltration, whereas
non-expanded scaffolds only have surface cellular attachment. Compared to
unexpanded nanofiber scaffolds, more CD68+ and CD163+ cells are observed
within expanded scaffolds at all tested time points post-implantation. More
CCR7+ cells appear within expanded scaffolds at week 8 post-implantation.
In addition, new blood vessels are present within the expanded scaffolds at
week 2. The formed multinucleated giant cells within expanded scaffolds are
heterogeneous expressing CD68, CCR7, or CD163 markers. Together, the
present study demonstrates that the expanded nanofiber scaffolds promote
cellular infiltration/tissue integration, a regenerative response, and neovascularization after subcutaneous implantation in rats. The use of expanded
electrospun nanofiber scaffolds offers a promising method for in situ tissue
repair/regeneration and generation of 3D tissue models/constructs.

1. Introduction
Electrospinning is an enabling technology that can produce a
matrix reminiscent of extracellular matrix found in a variety of
tissues and organs, which are synthesized and hierarchically
organized into fibrillar form with fiber dimensions down to
nanometer scale.[1–3] Electrospun nanofibers can also provide
a large surface area-to-volume ratio ideal for immobilizing
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board, electrospinning zein, and keratin scaffolds with fibers
oriented randomly and evenly in 3D.[9] Based on a similar
principle, Jang and co-workers added salts to a polymer solution prior to electrospinning and produced a sponge nanofiber
matrix composed of multilayered nanofiber sheets.[10] Kwon
and co-workers exposed 2D poly(l-lactide) (PLLA) nanofiber
membranes to ultrasonication with different times and
obtained 3D nanofiber scaffolds with adjustable pore size and
thickness with longer treatment.[11] Alsberg and co-workers
further combined fiber–fiber charge repulsions and ultrasonication to fabricate highly porous alginate nanofiber
scaffolds.[12] Unfortunately, most studies have been limited to
the fabrication of 3D nanofiber scaffolds composed of random
nanofibers and/or certain materials. The resultant scaffolds
often had insufficient thickness, restricted geometries, and/
or uncontrolled porosity.[8–12] These fabricated scaffolds were
also associated with unordered structures and lack of nanotopographic cues that are critical for regeneration of highly
organized tissues such as tendon, nerve, and muscle.[13] In
addition, most of these 3D nanofiber scaffolds were only
examined either in vitro or in vivo with respect to cellular
infiltration, lacking the characterization of host response and
neovascularization.
Our recent study reported a modified gas-foaming
approach to expand electrospun nanofiber membranes in the
third dimension.[13] The expanded nanofiber scaffolds had
significantly higher porosity than traditional 2D nanofiber
membranes, while maintaining aligned nanotopography.
The expanded scaffolds also had a layered structure with
gap widths and layer thicknesses controllable on micrometer
scale, ideal for cell seeding and penetration. Robust cellular
infiltration and proliferation within expanded nanofiber
scaffolds were demonstrated in vitro. However, the usable
size and precise control of scaffold thickness were not fully
realized in previous work.[13] For example, the largest size
of fiber samples tested for expansion was ≈1 cm × 1 cm.[13]
Larger sizes of nanofiber membranes were not examined.
Furthermore, the thickness of scaffolds fabricated was primarily dependent on processing time. In order to optimize
this process for use in the production of scaffolds for tissue
repair/regeneration, a greater range of scaffold sizes (width,
length) and thicknesses are required. More precise control
of scaffold thickness is also desired in order to optimize the
translational potential of fabricated 3D nanofiber matrices.
Therefore, a robust method capable of producing expanded
electrospun nanofiber scaffolds with increased size and precise control of thickness is greatly needed. In addition, the
previous study only tested the in vitro cellular infiltration
for expanded nanofiber scaffolds.[13] The in vivo response of
expanded nanofiber scaffolds largely remains unknown. The
objectives of the present study were to fabricate expanded
nanofiber scaffolds with increased size and precise control
of thickness, and to examine the cellular infiltration, host
response, and neovascularization of expanded scaffolds after
subcutaneous implantation in rats. The findings of this study
aim to provide insight into the design of 3D biomimetic
scaffolds for tissue repair and regeneration in situ and engineering 3D tissue models/constructs in vitro.

2
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2. Results
2.1. Fabrication and Characterization of Expanded
Nanofiber Scaffolds
Previously we demonstrated that electrospun nanofiber mats
can be expanded in the third dimension after treatment with
aqueous NaBH4 solution.[13] However, the working size and
thickness control of these expanded scaffolds were somewhat limited. In the present report, we have described a
robust approach for fabrication of expanded nanofiber scaffolds with both a greater mat size and a precise control of
thickness by using a customized glass mold (Figure 1). We
were able to expand nanofiber scaffolds with a starting mat
size of 80 mm × 80 mm (increased from 10 mm × 10 mm;
see Figure S1, Supporting Information). In addition, the precise thickness control of these expanded scaffolds was achieved
using pre-designed glass spacers (Figure 1a).
Figure 2a shows the photographs of an unexpanded
nanofiber mat (left) and freeze-dried, expanded nanofiber scaffolds (30 mm × 50 mm) with thicknesses of 3 mm (middle)
and 10 mm (left). Figure 2b,c shows the photographs of the
sterilized 3 and 10 mm thick scaffolds immersed in saline
before subcutaneous implantation. Figure 2d shows scanning
electron microscopy (SEM) images of the cross section of an
unexpanded PCL nanofiber mat, indicating that the fiber mat
prior to expansion was composed of densely packed random
nanofibers. Figure 2e,f shows SEM images of the cross sections
of expanded 3 and 10 mm thick nanofiber scaffolds, displaying
layered structures. Increased gap distances were observed for
thicker nanofiber scaffolds. However, it seems that there was not
much difference between the layer thicknesses of 3 and 10 mm
thick nanofiber scaffolds. Based on SEM images, we also quantified the distribution of gap distances and layer thicknesses for
the cross sections of 3 and 10 mm thick nanofiber scaffolds.
Figure 2g shows the distributions of gap distances for the cross
sections. Thicker scaffolds had larger gap distances as the peak
shifted to the right with increasing the thickness. The gap
distances corresponding to the peaks were 10 and 20 μm on
the cross sections of 3 and 10 mm thick nanofiber scaffolds.
Interestingly, the distributions of layer thicknesses were similar
(Figure 2h). The layer thickness corresponding to the peak was
around 10 μm.

2.2. Simulation of Expanding Process of Nanofiber Membranes
The volume fractions of the gas during the expanding process,
including the bubble nucleation, growth, and coalescence, were
described in Figure 3. The volume of fluid (VOF) model tracked
the volumes of gas in each numerical grid. Specifically, the
blue region corresponds to near zero volume fraction of gas,
indicating a liquid phase. The red region with a unity volume
fraction indicated a gas phase. Here we tracked the gas–liquid
interface based on a given volume fraction of 0.5, i.e., each grid
at the interface that is half full with gas. Five inlets were constructed at the bottom layer to initiate the gas flow and mimic
the gas bubble nucleation (Figure S2, Supporting Information).

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 1. Schematic illustration of the fabrication of expanded PCL nanofiber scaffolds. a) A customized mold was made by a pair of glass sheets and
spacers, which was assembled by glue. A piece of plasma-treated PCL fiber mat was placed at the center of the mold. b) The PCL fiber mat together
with the mold was expanded in 1 m NaBH4 solution for 1 h at room temperature. c) The expanded PCL nanofiber scaffold was rinsed, vacuumed, and
freeze-dried using a lyophilizer. d) The glass mold was gently removed and the expanded PCL nanofiber scaffold was ready to be sterilized and used
for implantation.

It is clear that the nucleated bubbles grow bigger with the
continued production of gas till coalescence of adjacent bubbles
starting at 0.0003 s. A short distance between two nucleation sites led to earlier gas bubble coalescence. At 0.0011 s, a
bubble layer was formed to further expand the nanofiber scaffolds. This process was also speculated in our previous work.[13]
Results also demonstrated that gas bubbles bridging two layers
of scaffold were noncircular, which was different from classical free-floating gas bubbles. This could be due to the bubble
surface tension and the pressure gradient at both ends of the
scaffold. The flow dynamics of the expanding process could be
further used to optimize and control the spatial structure of
nanofiber scaffolds.

2.3. Qualitative Histology Analysis
In order to examine the cellular infiltration after subcutaneous implantation, we evaluated histological sections of the
implanted PCL scaffolds and surrounding tissues with hematoxylin and eosin (H&E) and Masson trichrome staining.
Figure 4 shows H&E staining of various scaffolds with
surrounding tissues after subcutaneous implantation for 1, 2, 4,
and 8 weeks. Unexpanded scaffolds only exhibited limited cellular penetration (Figure 4), except at occasional cracks within
the scaffolds. In the expanded 3 mm thick scaffolds, cellular
penetration was present from week 1; near complete penetration was present by week 8. For the expanded 10 mm thick
scaffolds, complete cellular penetration was present at week 8.
We also observed new blood vessel formation within expanded

Adv. Healthcare Mater. 2016,
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scaffolds at week 2, 4, and 8, as indicated by the red blood cells
(insets in Figure 4). In contrast, no blood vessel formation was
noted within the unexpanded scaffolds.
Figure 5 shows Masson’s trichrome staining of scaffolds
with surrounding tissue after explantation. The cellular
infiltration and new blood vessel formation showed a trend
similar to the H&E staining (Figure 4). In addition, initial collagen encapsulation of the implants was evident one week
after implantation. Qualitatively, the thickness of the collagen
capsule on unexpanded scaffolds tended to increase with time;
this progression was not apparent on the expanded scaffolds.
In addition, within-scaffold collagen deposition by infiltrated
cells was observed within the expanded nanofiber scaffolds at
week 4 and 8 (Figure 5). Multinucleated giant cells were present
at the edge of unexpanded scaffolds and 3 mm thick expanded
scaffolds at week 1, but not in the 10 mm expanded scaffolds
(Figure 6). The giant cells in unexpanded scaffolds mostly were
observed on the scaffold edges, while giant cells in expanded
random scaffolds mostly were adjacent to the newly formed
blood vessels. Similar results were observed for expanded
aligned PCL scaffolds (Figure S3, Supporting Information).

2.4. Quantification of Cell Infiltration, Neovascularization,
and Host Response
In order to fully understand the cellular infiltration, neovascularization, and host response, we quantified the depth of cell
penetration into scaffolds, blood vessel density within scaffolds,
the thickness of collagen fibrous capsules, and the number of

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 2. Morphological and structural characterizations of unexpanded and expanded random nanofiber scaffolds. a) Photographs of random PCL
nanofiber scaffolds prior to and after treatment with 1 m NaBH4 for 1 h using 3 and 10 mm molds. b,c) Photographs of expanded 3 and 10 mm thick
scaffolds in saline. SEM images showing the cross sections of random PCL fiber mats d) before and after expansion with e) 3 and f) 10 mm molds.
The scale bar in (d)–(f) is 20 μm. g) The distributions of gap distances between adjacent layers of expanded 3 and 10 mm thick nanofiber scaffolds.
h) The distributions of layer thicknesses of expanded 3 and 10 mm thick nanofiber scaffolds. Both the gap distance and layer thickness were quantified
using the Image J software based on SEM images.

giant cells per implant (Figure 7). The unexpanded nanofiber
scaffolds showed a marginal increase in the depth of cell penetration from around 49.9 μm at week 1 and 2 to 80 μm at week 4
and 8 after implantation (Figure 7a). The expanded 3 mm thick
scaffolds showed a steady increase of penetration depth from
67.1 μm at week 1, to 128.7 μm at week 2, to 171.5 μm at
week 4, and further to 314.3 μm at week 8 (Figure 7a). Similarly, the depth of cell penetration within expanded 10 mm
thick scaffolds increased from 90.2 μm at week 1, to 94.3 μm
at week 2, to 186.8 μm at week 4, and further to 441.1 μm at
week 8 (Figure 7a). The aligned expanded 3 mm thick scaffolds
showed a comparable depth of penetration as 3 and 10 mm
thick scaffolds at week 4 and 8. No newly formed blood vessels were seen within unexpanded scaffolds at all tested time
points (Figure 7b). Differently, expanded 3 and 10 mm thick
scaffolds showed a dramatic increase in blood vessel density
from zero at week 1, to 11.0 and 13.4 vessels mm−2 at week 2,
to 16.9 and 30.3 vessels mm−2 at week 4, and further to 22.7
and 31.0 vessels mm−2 at week 8 (Figure 7b). Aligned expanded
4
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3 mm thick scaffolds showed a similar level of blood vessel density as 3 and 10 mm thick scaffolds.
The unexpanded nanofiber scaffolds showed an increase
in the thickness of collagen fibrous capsules from 549.7 μm
at week 1, to 673.2 μm at week 2, to 668.0 μm at week 4, and
further to 840.6 μm at week 8 (Figure 7c). In contrast, the thicknesses of capsules for expanded 3 mm thick scaffolds decreased
from 523.7 μm at week 1, to 437.0 μm at week 2, to 290.0 μm
at week 4, and further to 348.9 μm at week 8 (Figure 7c). The
thickness of fibrous capsules of expanded 10 mm thick
scaffolds was comparable to that of 3 mm thick scaffolds
(Figure 7c). For the aligned expanded 3 mm thick scaffolds, the
thickness of collagen fibrous capsules showed a slight increase
from 128.9 μm at week 1 to 254.2 μm at week 2, then remained
almost constant at week 4 and week 8 (Figure 7c).
The number of giant cells per implant for unexpanded
nanofiber scaffolds was about 16 at week 1, 9 at week 2, 3 at
week 4, and 6 at week 8 (Figure 7d). In comparison, the number
of giant cells per implant for expanded 3 mm thick scaffolds

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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The 10 mm thick scaffolds showed the greatest number of penetrating macrophages at week 8 (Figure S4, Supporting Information), with a similar spatiotemporal distribution of M1 and
M2 phenotypes (Figures S5–S7, Supporting Information).

2.6. Quantification of Macrophage Phenotype

Figure 3. The simulated expanding process of electrospun nanofiber
membranes.

was 16 at week 1, 28 at week 2, 31 at week 4, and 50 at week 8
(Figure 7d). Expanded 10 mm thick scaffolds showed a comparable number of giant cells per implant as 3 mm thick scaffolds
at week 4 and 8 (Figure 7d). Differently, the number of giant
cells per implant for aligned 3 mm thick scaffolds increased
from week 1 (24) to week 2 (44) and then decreased to 20 at
week 4, and further to 13 at week 8 (Figure 7d).

2.5. Immunostaining of Macrophage Phenotype
In order to understand the phenotypes of infiltrated macro
phages in scaffolds or in the surrounding areas, we performed
immunostaining of scaffolds and surrounding tissues after
explantation using three macrophage markers against CCR
7 (a surface marker for M1 macrophage phenotype), CD163
(a surface marker for M2 macrophage phenotype), and CD68
(a general macrophage marker).[14,15] Figures S4–S7 (Supporting Information) show the spatiotemporal distribution
of all macrophages, M1 macrophages, and M2 macrophages
within scaffolds and surrounding tissues. As expected, unexpanded scaffolds displayed limited macrophage infiltration
(Figure S4, Supporting Information), mostly appearing at week
4 and 8. In the expanded scaffolds, macrophages penetration
into scaffolds was apparent at week 1, and increased thereafter.

Adv. Healthcare Mater. 2016,
DOI: 10.1002/adhm.201600808

In order to better understand the phenotypes of infiltrated
macrophages, we quantified the number of macrophages
in each phenotype per immunohistochemical image (40×)
(Figure 8a–c). The unexpanded nanofiber scaffolds showed
a slight increase in the number of CD68+ cells from 30 at
week 1, to 33 at week 2, to 38 at week 4, and decreased to 24 at
week 8 (Figure 8a). Expanded 3 mm thick scaffolds showed a
constant number (54) of CD68+ cells during the testing period.
In contrast, 10 mm and aligned 3 mm thick scaffolds showed a
dramatic increase in the number of CD68+ cells from 49 and 45
at week 1, to 56 and 46 at week 2, to 85 and 78 at week 4, and
further to 88 and 91 at week 8 (Figure 8a).
The number of CCR7+ cells for unexpanded nanofiber scaffolds was 40 at week 1, 41 at week 2, 42 at week 4, and 15 at
week 8 (Figure 8b). Expanded 3 mm thick scaffolds showed a
slight increase in the number of CCR7+ cells from 39 at week 1,
to 48 at week 2, then decreased to 34 at week 4, and further to
25 at week 8. In contrast, 10 mm and aligned 3 mm thick scaffolds showed a gradual increase in the number of CCR7+ cells
from 31 and 32 at week 1, to 43 and 39 at week 2, to 47 and
58 at week 4, and further to 57 and 61 at week 8 (Figure 8b).
The numbers of CD163+ cells per snap shot for unexpanded
nanofiber scaffolds were 27, 26, 30, and 20 at week 1, 2, 4, and
8 (Figure 8c). The numbers of CD163+ cells for expanded 3 mm
scaffolds were similar at different time points (41, 49, 46, and
49 CD163+ cells per snap shot at week 1, 2, 4, and 8). Expanded
10 mm scaffolds showed an increase in the number of CD163+
cells per snap shot from 46 at week 1, to 47 at week 2, to 62
at week 4, and further to 72 at week 8 (Figure 8c). The corresponding numbers of CD163+ cells for the aligned 3 mm thick
scaffolds were 35, 32, 48, and 57 at week 1, 2, 4, and 8. Figure 8d
shows that expanded 10 mm thick scaffolds had higher ratios
of M2/M1 at week 1 and 4 compared to unexpanded scaffolds.
However, no significant difference in the ratio of M2/M1 was
observed between the tested groups at week 8. In addition,
expanded 3 mm thick scaffolds showed higher M2/M1 ratio
than that of unexpanded counterparts.

2.7. Heterogeneity of Multinucleated Giant Cells
To understand the heterogeneity of multinucleated giant cells,
we further analyzed the corresponding high-magnification
images of Figures S4–S6 (Supporting Information). For random
nanofiber scaffolds including unexpanded and expanded, the
formed multinucleated giant cells expressed CD 68, CCR 7,
and CD 163 markers (Figures S8–S10, Supporting Information). The expanded, aligned nanofiber scaffolds showed
similar results (Figure S11, Supporting Information). We also
quantified the number of CD 68+, CCR 7+, CD 163+, and the
ratio of CD163+/CCR7+ multinucleated giant cells (Figure S12,

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 4. H&E staining of random PCL nanofiber scaffolds and surrounding tissues. The unexpanded (raw) and expanded 3 and 10 mm thick nanofiber
scaffolds were subcutaneously implanted to rats for 1, 2, 4, and 8 weeks. Insets show high magnification of green square areas in the corresponding
images.

Supporting Information). Multinucleated giant cells expressed
heterogeneous markers including CD 68, CCR7, and CD 163
(Figure S12a–c, Supporting Information). The number of
CD163+ giant cells was usually higher than that of CCR7+ giant
cells except for expanded 10 mm thick random scaffolds at
week 2 and unexpanded scaffolds at week 4 (Figure S12d, Supporting Information). Expanded random nanofiber scaffolds
with 3 mm thick showed the highest ratios of CD163+/CCR7+
multinucleated giant cells from week 2 to week 8 among the
tested groups (Figure S12d, Supporting Information).

2.8. Immunostaining of Inflammatory and
Anti-Inflammatory Cytokines
To further understand the effect of cytokines produced within
scaffolds or in surrounding areas on the tissue regeneration,
6
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we performed immunostaining of scaffolds and surrounding
tissues after explantation at week 1, 2, 4, and 8 using three
different markers against IL-4 and IL-10 (anti-inflammatory
cytokines) and TNF-α (pro-inflammatory cytokine).[16,17]
Figures S13–S16 (Supporting Information) show the spatiotemporal distribution of IL-4, IL-10, and TNF-α within scaffolds
and surrounding areas. As expected, unexpanded scaffolds
only displayed limited infiltration for IL-4 (Figures S13 and
S16, Supporting Information), IL-10 (Figures S14 and S16,
Supporting Information), and TNF-α (Figures S15 and S16,
Supporting Information), and their secretion level remained
unchanged from week 1 to week 8. The IL-4 positive staining
mainly located at the surrounding area of unexpanded scaffolds.
For expanded scaffolds, IL-4 cytokines started expressing within
the scaffolds from week 1 (Figure S13, Supporting Information). More IL-4 cytokines were accumulated within expanded
scaffolds with increasing the implantation time (Figure S13,

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 5. Masson’s trichrome staining of random PCL nanofiber scaffolds and surrounding tissues. Masson’s trichrome staining indicates collagen in
blue, nuclei in black, and cytoplasm and keratin in red. The unexpanded (raw) and expanded 3 and 10 mm thick nanofiber scaffolds were subcutaneously implanted to rats for 1, 2, 4, and 8 weeks. Insets show high magnification of green square areas in the corresponding images.

Supporting Information). Obviously, the 10 mm thick scaffolds showed the highest level of IL-4 secretion at week 8
(Figures S13 and S15, Supporting Information). Intriguingly,
IL-10 and TNF-α positive staining showed a similar spatiotemporal distribution within scaffolds as IL-4 (Figures S14–S16,
Supporting Information). However, the level for TNF-α staining
seemed much lower than that of IL-4 and IL-10.

3. Discussion
For tissue repair/regeneration, scaffolds/implants may play
an important role for homing cells from surrounding healthy
tissues and form new tissues to repair the defected tissues.[18]
Therefore, for sucessful in situ tissue regeneration, promoting
cell ingrowth is one of the prerequisites for an ideal 3D scaffold.
Studies have shown that cell infiltration is mainly determined

Adv. Healthcare Mater. 2016,
DOI: 10.1002/adhm.201600808

by the architecture or structure of scaffolds.[19] This is, in particular, critical for synthetic scaffolds as cells often fail to
immediately disintegrate the artificial extracellular matrices for
migration.[19] Hence, cell ingrowth greatly relies on the porosity
and pore size of scaffolds, which is especially true for non-biodegradable or slowly biodegradable materials. In a recent study,
Jang and co-workers reported the cell infiltration within layered
PCL nanofiber scaffolds after subcutaneous implantation in
nude mice for six weeks, which were produced by electrospinning highly conductive solutions with additives of ionic salts.[10]
Cellular infiltration was observed, however, only one time point
(six weeks) was examined. In addition, the porosity and the
distribution of gap distances between adjacent layers were not
reported.[10] The present study demonstrated the fabrication
of expanded 3 and 10 mm nanofiber scaffolds with porosities
of ≈90% and ≈100%, respectively. The gaps between most
adjacent layers ranged from several micrometers to ≈100 μm

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 6. Multinucleated giant cells after random PCL nanofiber scaffold implantation. Masson’s trichrome staining of random PCL nanofiber scaffolds
after rat subcutaneous implantation. The rats were scarified at week 1, 2, 4, and 8 after surgery. Giant cells indicated by green arrows were found around
and inside of PCL nanofiber scaffolds.

(Figure 2g). The dynamic process of cell penetration was shown
from week 1 to week 8, suggesting that cells may fully penetrate throughout the whole scaffold within eight weeks, mainly
dependent on the porosity (Figures 4 and 5). Cells penetrated
throughout the whole expanded 3 and 10 mm thick random
scaffolds within eight weeks. The aligned expanded 3 mm
thick scaffolds showed a similar penetration depth as expanded
3 and 10 mm thick random scaffolds at week 8. In addition,
the unexpanded PCL nanofiber scaffolds exhibited very limited
cellular infiltration on the surface layer, which agreed well with
previous reports.[13]
Sufficient oxygen and nutrient transport to the infiltrated
cells within scaffolds is the key to form functional tissues in
clinically relevant dimensions.[20] Therefore, another important aspect for in situ tissue regeneration is neovascularization.
Many attempts have been made to promote vascularization
including scaffold design, endothelial cell pre-seeding, and
8
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incorporation of bioactive molecules.[21] Among them, the pore
architecture and porosity of scaffolds play a critical role on the
formation of new blood vessles via sprouting from host vasculature.[22] Beier and co-workers examined the actual pattern
of vascularization in PCL/collagen nanofiber scaffolds using
micro-CT scans and found the aligned scaffold showed a significantly smaller number of sprouting vessels but vascularization
in the center of the constructs occurred considerably earlier
than in the nonwoven scaffold.[23] In a separate study, Andreopoulos and co-workers showed that aligned electrospun gelatin
nanofibers containning bFGF had the highest vessel density
(33 vessels mm−2) comparing to other groups including aligned
fibers and random fibers with and without containing bFGF
(5 vessles mm−2) after implantation in the mouse’s hindlimb
for 21 d.[24] Park and co-workers also examined the vascularization of 1–1.5 mm thick ten-layered PCL/collagen nanofiber
scaffolds formed by manually folding after subcutaneous

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 7. Quantification of histological analysis of PCL nanofiber scafflods after subcutaneous implantation. a) Cell penetration, b) blood vessels
density, c) capsule thickness, and d) number of giant cells. The values were obtained by measuring six scanning images at 40× (objective lense)
magnification for each specimen.

implantation in rats.[25] Dunn and co-workers developed a
laser cutting pores in traditional nanofiber membranes for
enhancement of vascular ingrowth.[26] In this work, no blood

vessels were observed within unexpanded nanofiber scaffolds
at all time points because of very limited cellular infiltration
on the surface layer. Within expanded PCL nanofiber scaffolds

Figure 8. Quantification of immunhistological analysis of PCL nanofiber scafflods after subcutaneous implantation. a) CD 68, b) CCR 7 (M1), c) CD
163 (M2) immunpositve cells, and d) ratio of number of CD163 positive cells (M2)/number of CCR7 positive cells (M1). The values were obtained by
measuring six scanning images at 40× (objective lense) magnification for each specimen.
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new blood vessels appeared at week 2 and blood vessel density increased with increasing implantation time and reached
30 vessels mm−2 at week 8, which is comparable to the aligned
gelatin nanofibers containing bFGF (33 vessels mm−2). In addition, expanded 10 mm thick scaffolds usually showed higher
number of blood vessels per unit area within scaffolds than that
of 3 mm thick ones (Figure 7b). The blood vessel density within
aligned expanded 3 mm thick scaffolds was similar to that of
10 mm thick scaffolds at week 4 and 8.
Implants require tissue engraftment and vascularization to
generate functional tissues for replacement/repair/regeneration. Host response to implantated scaffolds is very important
to determine their success after implantation. The biological
response has been examined on various biomaterials with different sizes, compositions, and shapes.[27] However, the host
respone to electrospun nanofiber scaffolds was not fully illustrated and most of work was limited to the investigation of
traditional 2D electrospun nanofiber membranes. Chew et al.
examined host response of PCL nanofiber membranes and
found that aligned nanofibers can minimize host response,
enhance tissue-scaffold integration, and elicit a thinner fibrous
capsule compared with random nanofibers.[28] In the present
study, expanded nanofiber scaffolds displayed thinner fibrous
capsules compared to 2D nanofiber membranes. Expanded
3 and 10 mm thick scaffolds presented the similar thickness
of fibrous capsules. The aligned expanded 3 mm thick scaffolds showed thinner fibrous capsules than expanded 3 and
10 mm thick scaffolds. Expanded nanofiber scaffolds showed
the infiltration of macrophages in different phenotypes and
induction of heterogenous multinucleated giant cells within the
scaffolds, which could be critical for the neovascularization and
regeneration process.[29–33] The expanded 10 mm thick scaffolds
had the highest number of infiltrating macrophages at week 8
(Figure S4, Supporting Information). The number of giant cells
per implant was comparable for expanded 3 and 10 mm thick
scaffolds at week 4 and 8. Interestingly, expanded 3 mm thick
scaffolds showed the highest M2/M1 ratio of multinucleated
giant cells. In addition, the number of giant cells per implant
for aligned 3 mm thick scaffolds was much lower compared to
random 3 and 10 mm thick scaffolds at week 8. The multinucleated giant cells present within aligned 3 mm thick scaffolds
showed heterogeneous markers including CD 68, CCR7, and
CD 163 similar to other scaffolds. Recent studies suggested that
a porous polymer with interconnected pores (≈40 μm in size)
can form vascularized tissues with little or no fibrosis and good
resoration of vascularity, whereas the same polymer in solid
form triggers the classic foreign body reaction characterized
by a dense, collagen fibrous capsule and low vascularity.[34] Our
results are in line with this finding as the expanded scaffolds
show the distances of gaps between layers ranging from several
micrometers to about 100 μm. Importantly, expanded nanofiber
scaffolds showed IL-4 cytokine expression at week 1 and an
increased IL-4 production within scaffolds with increasing
the implantation time. Expanded 10 mm thick scaffolds demonstrated the highest expression of IL-4 within scaffolds at
week 8 among all the tested scaffolds. IL-4 could be produced by
T helper 2 cells and guided the polarization of infiltrated macrophages, providing a pro-regenerative microenvironment.[35]
In addition, the incorporation of anti-inflammatory drugs to
10
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the nanofibers could further reduce the thickness of collagen
fibrous capsules.[36] The incorporation of immunmodulating
agents to scaffolds for sustained release could temperoally control the phenotypes of macrophages infiltrated.[37]

4. Conclusion
We have developed a robust method for producing expanded
nanofiber scaffolds with controlled size and thickness using a
custermized mold during the modified gas-foaming process.
We demonstrated the evident cellular infiltration and new blood
vessel formation within expanded nanofiber scaffolds after subcutaenous implantation in rats. We also observed that expanded
scaffolds elicited a thinner collagen fibrous capsule compared
to unexpanded nanofiber scaffolds and promoted a regenerative
response. Gap distances between adjacent layers, layer thickness, porosity, and fiber alignment mainly determined cellular
infiltration, vascularization, and host response. In summary,
such expanded nanofiber scaffolds hold great potential for use
in tissue repair/regeneration in situ, the development of various
3D tissue models/constructs in vitro, and wound dressings.

5. Experimental Section
See the Supporting Information.

Supporting Information
Supporting Information is available from the Wiley Online Library or
from the author.
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